Prognosis and management of chronic kidney disease (CKD) at the end of life

Postgraduate Medical Journal

Volumn 90, Issue 1060, 2014, Pages 98-105

  Davison, Rachel ^a   Sheerin, Neil S ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; BICARBONATE; DIURETIC AGENT; ERYTHROPOIETIN; IRON; PHOSPHATE BINDING AGENT; VITAMIN D;

ACIDOSIS; ANEMIA; ANOREXIA; BONE PAIN; CHRONIC KIDNEY DISEASE; CONSERVATIVE TREATMENT; DEATH; DECISION MAKING; DYSPNEA; EDEMA; END STAGE RENAL DISEASE; FATIGUE; FLUID RETENTION; FRAGILITY FRACTURE; HEMODIALYSIS; HUMAN; ILLNESS TRAJECTORY; LIFE EXPECTANCY; NAUSEA AND VOMITING; NEPHROLOGIST; PAIN; PALLIATIVE THERAPY; PATIENT CARE; PERITONEAL DIALYSIS; PREVALENCE; PROGNOSIS; RENAL REPLACEMENT THERAPY; REVIEW; TERMINAL CARE; TREATMENT WITHDRAWAL;

ADVANCE CARE PLANNING; AGED; AGED, 80 AND OVER; COMORBIDITY; DECISION MAKING; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; NEPHROLOGY; PALLIATIVE CARE; PATIENT CARE TEAM; PATIENT PREFERENCE; PREVALENCE; PROGNOSIS; QUALITY OF LIFE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; SURVIVAL RATE; TREATMENT REFUSAL;

EID: 84892895388     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/postgradmedj-2013-132195     Document Type: Review

References (100)

1. Stevens PE, O'Donoghue DJ, De Lusignan S, et al. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int 2007;72:92-99.
2. Gilg J, Castledine C, Fogarty D. UK renal registry 14th annual report (2011)- chapter 1: UK renal replacement therapy incidence in 2010: national and centre-specific analyses. Renal Association Publishing. http://www.renalreg.com/Reports/2011.html (accessed 4 May 2013).
3. Wang H, Dwyer-Lingren L, Lofgren K, et al. Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2071-2094.
4. Coresh J, Astor BC, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003;41:1-12.
5. Stevens LA, Viswanathan G, Weiner DE. CKD and ESRD in the elderly: current prevalence, future projections, and clinical significance. Adv Chronic Kidney Dis 2010;17:293-301.
6. Williams ME, Sandeep J, Catic A. Aging and ESRD demographics: consequences for the practice of dialysis. Semin Dial 2012;25:617-622.
7. Steenkamp R, Castledine C, Feest T. UK renal registry 14th annual report (2011) -chapter 6: survival and causes of death of UK adult patients on renal replacement therapy in 2010: national and centre-specific analyses. Renal Association Publishing. http://www.renalreg.com/Reports/2011.html (accessed 4 May 2013).
8. Nordio M, Limido A, Maggiore U, et al. Survival in patients treated by long-term dialysis compared with the general population. Am J Kidney Dis 2012;59:819-828.
9. Chandna SM, Schulz J, Lawrence C, et al. Is there a rationale for rationing chronic dialysis? A hospital based cohort study of factors affecting survival and morbidity. BMJ 1999;318:217-223.
10. Wright LF. Survival in patients with endstage renal disease. Am J Kidney Dis 1991;17:25-28.
11. Khan IH, Catto GRD, Edward N, et al. Influence of coexisting disease on survival on renal replacement therapy. Lancet 1993;341:415-418.
12. Canaud B, Tong F, Tentori F, et al. Clinical practice and outcomes in elderly hemodialysis patients: results from the dialysis outcomes and practice patterns study (DOPPS). Clin J Am Soc Nephrol 2011;6:1651-1662.
13. Kurella TM, Covinsky M, Chertow G, et al. Functional status of elderly adults before and after initiation of dialysis. N Engl J Med 2009;361:1539-1547.
14. Murtagh FEM, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chr Kidney Dis 2007;14:82-99.
15. Murtagh FEM. Understanding and improving quality of care for people with conservatively managed stage 5 chronic kidney disease-the course of symptoms and other concerns over time [PhD thesis]. King's College London.
16. O'Hare AM. The management of older adults with a low eGFR: moving toward an individualized approach. Am J Kidney Dis 2009;53:925-927.
17. Fassett RG, Robertson IK, Mace R, et al. Palliative care in end-stage kidney disease. Nephrology 2011;16:4-12.
18. Murtagh FEM, Sheerin N. Conservative management of end stage renal disease. In: Chambers J, Brown E, Germain MJ, eds. Supportive care for the renal patient. Oxford, UK: Oxford University Press, 2010:253-68.
19. Smith C, Da Silva-Gane M, Chandna S, et al. Choosing not to dialyse: evaluation of planned non-dialytic management in a cohort of patients with end-stage renal failure. Nephron Clin Pract 2003;95:40-46.
20. Carson RC, Juszczak M, Davenport A, et al. Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease? Clin J Am Soc Nephrol 2009;4:1611-1619.
21. Joly D, Anglicheau D, Alberti C, et al. Octogenarians reaching end-stage renal disease: cohort study of decision-making and clinical outcomes. J Am Soc Nephrol 2003;14:1012-1021.
22. Chandna SM, Da Silva-Gane M, Marshall C, et al. Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy. Nephrol Dial Transplant 2011;26:1608-1614.
23. Murtagh FEM, Marsh JE, Donohoe P, et al. Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transplant 2007;22:1955-1962.
24. Harris SA, Lamping DL, Brown EA, et al. Clinical outcomes and quality of life in elderly patients on peritoneal dialysis versus hemodialysis. Perit Dial Int 2002;22:463-470.
25. Lamping DL, Constantinovici N, Roderick P, et al. Clinical outcomes, quality of life, and costs in the North Thames Dialysis Study of elderly people on dialysis: a prospective cohort study. Lancet 2000;356:1543-1550.
26. Couchoud C, Moranne O, Frimat L, et al. Associations between comorbidities, treatment choice and outcome in the elderly with end-stage renal disease. Nephrol Dial Transplant 2007;22:3246-3254.
27. Winkelmayer W, Glynn R, Mittleman M, et al. Comparing mortality of elderly patients on haemodialysis versus peritoneal dialysis: a propensity score approach. J Am Soc Nephrol 2002;13:2353-2362.
28. Brown EA, Johansson L, Farrington K, et al. Broadening Options for Long-term Dialysis in the Elderly (BOLDE): differences in quality of life on peritoneal dialysis compared to haemodialysis for older patients. Nephrol Dial Transplant 2010;25:3755-3763.
29. Bargman JM. Peritoneal dialysis should be the first choice for renal replacement therapy in the elderly. Semin Dial 2012;25:668-674.
30. Mallappallil M, Patel A, Friedman EA. Peritoneal dialysis should not be the first choice for renal replacement therapy in the Elderly. Semin Dial 2012;25:668-674.
31. Dimkovic N, Aggarwal V, Khan S, et al. Assisted peritoneal dialysis: what is it and who does it involve? Adv Perit Dial 2009;25:165-170.
32. Brown EA. How to address barriers to peritoneal dialysis in the elderly. Perit Dial Int 2011;31:583-585.
33. Morton RL, Snelling P, Webster AC, et al. Factors influencing patient choice of dialysis versus conservative care to treat end-stage kidney disease. CMAJ 2012;184:277-283.
34. Wilkie M, Winterbottom AE, Gavaruzzi T, et al.; On behalf of the YoDDA team. Patient and staff views about the Yorkshire Dialysis Decision Aid (YoDDA) and it's usefulness in enabling patients' informed decision making: an interview study. Published in abstract format (poster presentation), British Renal Society Conference 2012. http://www.britishrenal.org/Conferences/Conferences-Home/BRS-Conference-2012/Poster-Programme-2012.aspx (accessed 21 May 2013).
35. Winterbottom AE, Bekker HL, Conner M, et al. Patient stories about their dialysis experience biases others' choices regardless of doctor's advice: an experimental study. Nephrol Dial Transplant 2012;27:325-331.
36. Murtagh FEM, Sheerin NS, Addington-Hall J, et al. Trajectories of illness in stage 5 chronic kidney disease: a longitudinal study of patient symptoms and concerns in the last year of life. Clin J Am Soc Nephrol 2011;6:1580-1590.
37. Murtagh FEM, Murphy E, Sheerin NS. Illness trajectories: an important concept in the management of kidney failure. Nephrol Dial Transplant 2008;6:1580-1590.
38. Murray SA, Kendall M, Boyd K, et al. Illness trajectories and palliative care. BMJ 2005;330:1007-1011.
39. Pattison M, Romer AL. Improving care through the end of life: launching a primary care clinic-based program. J Palliat Med 2001;4:249-254.
40. Moss AH, Ganjoo J, Sharma S, et al. Utility of the "Surprise" question to identify dialysis patients with high mortality. Clin J Am Soc Nephrol 2008;3:1379-1384.
41. Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symp Manag 2006;31:58-69.
42. Department of Health. Gold Standards Framework. 2006. http://www.goldstandardsframework.nhs.uk/gp_contract.php (accessed 20 May 2013).
43. Renal Physicians Association and American Society of Nephrology. Shared decision-making in the appropriate initiation of and withdrawal from dialysis, clinical practice guideline number 2. Pub Washington, DC: Renal Physicians Association, 2000.
44. Cohen LM, Ruthazer R, Moss AH, et al. Predicting six-month mortality for patients who are on maintenance hemodialysis. Clin J Am Soc Nephrol 2010;5:72-79.
45. Couchoud C, Labeeuw M, Moranne O, et al.; For the French Renal Epidemiology and Information Network (REIN) registry. A clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal disease. Nephrol Dial Transplant 2009;24:1553-1561.
46. Barrett B, Parfey P, Morgan J, et al. Prediction of early death in end stage renal disease patients starting dialysis. Am J Kidney Dis 1997;29:214-222.
47. Bradbury B, Fissell R, Albert J, et al. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Clin J Am Soc Nephrol 2007;2:89-99.
48. Burton J, Clipsham L, Cooke C, et al. Implementation of a supportive care register improves end of life care for patients with advanced chronic kidney disease. Oral presentation, British Renal Society Conference 2013. http://www.britishrenal.org/Conferences/Conferences-Home/BRS-Conference-2013/Thursday.aspx (accessed 21 May 2013).
49. U.S. Renal Data System, National Institutes of Health, and National Institute of Diabetes and Digestive and Kidney Diseases. USRDS 2007 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, 2007. http://www.usrds.org/atlas07.aspx (accessed 20 May 2013).
50. Sekkarie MA, Moss AH. Withholding and withdrawing dialysis: the role of physician speciality and education and patient functional status. Am J Kidney Dis 1998;31:464-472.
51. Steinman TI. The older patient with end-stage renal disease: is chronic dialysis the best option? Semin Dial 2012;25:602-610.
52. Davison SN. End-of-life care preferences and needs: perceptions of patients with chronic kidney disease. Clin J Am Soc Nephrol 2010;5:195-204.
53. Miura Y, Asai A, Matsushima M, et al. Families' and physicians' predictions of dialysis patients' preferences regarding life sustaining treatments in Japan. Am J Kidney Dis 2006;47:122-130.
54. Cohen LM, Germain MJ, Poppel DM. Practical considerations of dialysis withdrawal-'To have that option is a blessing'. JAMA 2003;289:2113-2119.
55. Quill TE. Initiating end-of-life discussions with seriously ill patients: addressing the "elephant in the room". JAMA 2000;284:2502-2507.
56. Chinnadurai R, Vassallo D, Robinson H, et al. Dialysis withdrawal and the impact of advanced care planning-a single centre experience. http://www.britishrenal.org/Conferences/Conferences-Home/BRS-Conference-2013/Thursday.aspx (accessed 21 May 2013).
57. Murtagh FEM, Cohen LM, Germain MJ. Dialysis discontinuation: quo vadis? Adv Chronic Kidney Dis 2007;14:379-401.
58. Mailloux LU, Bellucci AG, Napolitano B, et al. Death by withdrawal from dialysis-a twenty year experience. JASN 1993;3:1631-1637.
59. Holley JL. Withdrawing from dialysis-clinical experiences. Contemp Dial Nephrol 1998;19:29-30.
60. Cohen LM, Germain MJ, Poppel DM, et al. Dialysis discontinuation and palliative care. Am J Kid Dis 2000;36:140-144.
61. Cohen LM, Germain MJ, Poppel DM, et al. Dying well after discontinuing the life-support treatment of dialysis. Arch Intern Med 2000;160:2513-2518.
62. Murphy EL, Murtagh FE, Carey I, et al. Understanding symptoms in patients with advanced chronic kidney disease managed without dialysis: use of a short patient-completed assessment tool. Nephron Clin Prac 2009;111:74-80.
63. Davison SN. Integrating palliative care for patients with advanced chronic kidney disease-recent advances, remaining challenges. J Palliat Care 2011;27:53-61.
64. Pham PCT, Toscano E, Pham PMT, et al. Pain management in patients with chronic kidney disease. NDT Plus 2009;2:111-118.
65. Trivedi DD. Palliative dialysis in end-stage renal disease. Am J Hosp Palliat Med 2011;28:539-542.
66. National End of Life Care Programme/NHS Kidney Care-End of Life Care in Advanced Kidney Disease: A Framework for Implementation. 2009. http://www.endoflifecare.nhs.uk/search-resources/resources-search/publications/imported-publications/end-of-life-care-in-advanced-kidney-disease.aspx (accessed 19 May 2013).
67. Janssen DJA, Spruit MA, Wouters EFM, et al. Daily symptom burden in end-stage chronic organ failure: a systematic review. Palliat Med 2008;22:938-948.
68. Abdel-Kader K, Unruh ML, Weisbord SD. Symptom burden, depression, and quality of life in chronic and end-stage kidney disease. Clin J Am Soc Nephrol 2009;4:1057-1564.
69. Murtagh FEM, Addington-Hall JM, Edmonds PM, et al. A cross-sectional survey of symptom prevalence in stage 5 CKD managed without dialysis. J Pall Med 2007;10:1266-1276.
70. Weisbord SD, Fried LF, Mor MK, et al. Renal provider recognition of symptoms in patients on maintenance hemodialysis. Clin J Am Soc Nephrol 2007;2:960-967.
71. Claxton RN, Blackhall L, Weisbord SD, et al. Undertreatment of symptoms in patients on maintenance hemodialysis. J Pain Symptom Manage 2010;39:211-218.
72. Cardenas DD, Kutner NG. The problem of fatigue in dialysis patients. Nephron 1982;30:336-340.
73. Ramkumar N, Beddhu S, Eggers P, et al. Patient preferences for in-center intense hemodialysis. Hemodial Int 2005;9:281-295.
74. Weisbord SD, Fried LF, Arnold RM, et al. Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients. J Am Soc Nephrol 2005;16:2487-2494.
75. Newton JL, Brown A, Jones DEJ, et al. Fatigue in early renal disease. Br J Ren Med 2009;14:10-14.
76. Davies G, Kingswood C, Street M. Pharmacokinetics of opioids in renal dysfunction. Clin Pharmacokinet. 1996;31:410-422.
77. Mercadante S, Arcuri E. Opioids and renal function. J Pain 2004;5:2-19.
78. Murtagh FEM, Chai MO, Donohoe P, et al. The use of opioid analgesia in end-stage renal disease patients managed without dialysis: recommendations for practice. J Pain Palliat Care Pharmacother 2007;21:5-16.
79. Davison SN. Advance care planning in patients with chronic kidney disease. Semin Dial 2012;25:657-663.
80. Pfeifer MP, Sidorov JE, Smith AC, et al. The discussion of end-of-life medical care by primary care patients and physicians: a multicenter study using structured qualitative interviews (The EOL Study Group). J Gen Intern Med 1994;9:82-88.
81. Davison SN, Simpson C. Hope and advance care planning in patients with end stage renal disease: qualitative interview study. BMJ 2006;333:886-890.
82. Wright AA, Zhang B, Ray A, et al. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA 2008;300:1665-1673.
83. Swidler M. Chapter 37, Dialysis decisions in the elderly patient with advanced CKD and the role of non-dialytic therapy. In: Oreopoulos D, Wiggins J, eds. American society of nephrology geriatric nephrology curriculum. Washington, DC. American Society of Nephrology, 2009. http://www.asn-online.org/education/distancelearning/curricula/geriatrics/Chapter37.pdf (accessed 27 May 2013).
84. Swidler MA. Geriatric renal palliative care. J Gerontol A Biol Sci Med Sci 2012;67:1400-1409.
85. Murray AM, Tupper DE, Knopman DS, et al. Cognitive impairment in haemodialysis patients is common. Neurology 2006;67:216-223.
86. Madero M, Gul A, Sarnak MJ. Cognitive function in chronic kidney disease. Semin Dial 2008;21:29-37.
87. Madan P, Kalra OP, Agarwal S, et al. Cognitive impairment in chronic kidney disease. Nephrol Dial Transplant 2007;22:440-444.
88. Kurella M, Mapes DL, Port FK, et al. Correlates and outcomes of dementia among dialysis patients: the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant 2006;21:2543-2548.
89. Fine A, Fontaine B, Kraushar MM, et al. Nephrologists should voluntarily divulge survival data to potential dialysis patients: a questionnaire study. Perit Dial Int 2005;25:269-273.
90. Moss AH, Hozayen O, King K, et al. Attitudes of patients toward cardiopulmonary resuscitation in the dialysis unit. Am J Kidney Dis 2001;38:847-852.
91. Ostermann ME, Nelson SR. Haemodialysis patients' views on their resuscitation status. Nephrol Dial Transplant 2003;18:1644-1647.
92. Moss AH, Holley JL, Upton MB. Outcomes of cardiopulmonary resuscitation in dialysis patients. J Am Soc Nephrol 1992;3:1238-1243.
93. Lai M, Hung K, Huang J, et al. Clinical findings and outcomes of intra-hemodialysis cardiopulmonary resuscitation. Am J Nephrol 1999;19:468-473.
94. Lafrance JP, Nolin L, Senecal L, et al. Predictors and outcome of cardiopulmonary resuscitation (CPR) calls in a large haemodialysis unit over a seven-year period. Nephrol Dial Transplant 2006;21:1006-1012.
95. Schell JO, Arnold RM. NephroTalk: communication tools to enhance patient-centered care. Semin Dial 2012;25:611-616.
96. Department of Health. Adult renal dialysis best practise tariffs (2012-2013). http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_132654 (Accessed 28 May 2013).
97. Murray AM, Arko C, Chen SC, et al. Use of hospice in the United States dialysis population. Clin J Am Soc Neph 2006;1:1248-1255.
98. Hobson K, Gomm S, Murtagh F, et al. National survey of the current provision of specialist palliative care services for patients with end-stage renal disease. Nephrol Dial Transplant 2011;26:1275-1281.
99. Murtagh FEM, Murphy E, Shepherd KA, et al. End of life care in end-stage renal disease: renal and palliative care. Brit J Nursing 2006;15:8-11.
100. Murtagh FEM. Palliative care in renal disease: lessons for other conditions? Eur J Pall Care 2011;18:213.